共 140 条
[1]
Tjitra E(2008)Multidrug-resistant PLoS Med 5 e128-725
[2]
Anstey NM(2017) associated with severe and fatal malaria: a prospective study in Papua, Indonesia BMC Infect Dis 17 794-1657
[3]
Sugiarto P(2012)Intravenous artesunate plus Artemisinin-based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial PLoS ONE 7 e45645-1062
[4]
Warikar N(2005)Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia Lancet 366 717-550
[5]
Kenangalem E(2010)Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial Lancet 376 1647-359
[6]
Karyana M(2018)Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial Clin Infect Dis 67 1053-S90
[7]
Byakika-Kibwika P(2015)A competing-risk approach for modeling length of stay in severe malaria patients in South-East Asia and the implications for planning of hospital services Malar J 14 226-16
[8]
Achan J(2008)An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study Malar J 7 148-1422
[9]
Lamorde M(2018)Malaria morbidity in Papua Indonesia, an area with multidrug resistant Am J Trop Med Hyg 98 543-187
[10]
Karera-Gonahasa C(2019) and PLoS Med 16 e1002815-765